According to a recently published clinical study by the department of Dietetics, Nutrition and Biological Sciences, those supplementing with Euromed’s natural extract Pomanox showed significantly lower levels of hunger and a desire to eat. The group also showed higher levels of satiety, compared to a placebo group.
In the preliminary, independent, placebo-controlled study conducted at Queen Margaret University, Edinburgh, 28 healthy subjects were given either three week supplementation with Pomanox or a placebo. During week three, satiety parameters were determined on a testing day after participants ingested breakfast and lunch with pomegranate juice (PJ).
The results suggest that subjects in the Pomanox group with the PJ preload were generally more satisfied than those given the placebo. Participants were also less hungry after Pomanox intake with PJ during the meal than those who consumed placebo juice and capsules. Scores from the visual analogue scales (VAS), which record subjective sensations, showed significantly lower levels of hunger and a desire to eat, as well as higher levels of fullness and satisfaction, thus greater levels of satiety in participants consuming Pomanox with PJ, compared to the placebo.
These participants also liked the smell of the meal significantly more than the placebo group. Interestingly, the consumption of pomegranate extract was associated with a significantly lower amount of food intake during the satiety session compared with the placebo group.
Their production is vertically integrated as they originate from selected fruits grown in the Mediterranean region - close to our dedicated manufacturing plant and in accordance with strict and transparent quality control protocols. In summary, they are ideal for inclusion in premium dietary supplements, functional foods and pharmaceuticals
While preliminary, these findings confirm the appetite-regulating effect of polyphenol-rich extracts reported in previous studies, suggesting possible novel new approaches to reducing risk factors for obesity and compulsive eating, and providing more enjoyable meals while dieting.
Andrea Zangara, Scientific Marketing Manager at Euromed, said: “We are very pleased to see these promising results, as they further support the efficacy and safety of Pomanox, expanding its numerous evidence-based health applications to include weight management and behavioural support. Pomanox is available in different formats and strengths, and extracted using safe and eco-friendly, water-only technologies (Pure-Hydro Process) as with all the other ingredients in our line of Mediterranean Fruit and Vegetable Extracts.”
Euromed is a vertically integrated leading producer of standardised botanical extracts and natural active substances for the pharmaceutical, nutraceutical, food and cosmetic industries.
Zangara continued: “Their production is vertically integrated as they originate from selected fruits grown in the Mediterranean region - close to our dedicated manufacturing plant and in accordance with strict and transparent quality control protocols. In summary, they are ideal for inclusion in premium dietary supplements, functional foods and pharmaceuticals.”
